BioMarin Pharmaceutical Statistics

Total Valuation

BIT:1BMRN has a market cap or net worth of EUR 10.17 billion. The enterprise value is 9.58 billion.

Market Cap	10.17B
Enterprise Value	9.58B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.65%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.58M

Valuation Ratios

The trailing PE ratio is 20.99.

PE Ratio	20.99
Forward PE	n/a
PS Ratio	3.73
PB Ratio	1.90
P/TBV Ratio	2.06
P/FCF Ratio	17.62
P/OCF Ratio	15.70
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.16, with an EV/FCF ratio of 16.59.

EV / Earnings	19.76
EV / Sales	3.66
EV / EBITDA	13.16
EV / EBIT	15.10
EV / FCF	16.59

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.10.

Current Ratio	5.52
Quick Ratio	3.20
Debt / Equity	0.10
Debt / EBITDA	0.73
Debt / FCF	0.96
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 7.12%.

Return on Equity (ROE)	9.64%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	7.12%
Return on Capital Employed (ROCE)	10.98%
Revenue Per Employee	897,878
Profits Per Employee	159,440
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.07%
50-Day Moving Average	61.35
200-Day Moving Average	65.89
Relative Strength Index (RSI)	21.05
Average Volume (20 Days)	22

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.99

Income Statement

In the last 12 months, BIT:1BMRN had revenue of EUR 2.73 billion and earned 484.70 million in profits. Earnings per share was 2.50.

Revenue	2.73B
Gross Profit	2.21B
Operating Income	661.96M
Pretax Income	623.87M
Net Income	484.70M
EBITDA	746.28M
EBIT	661.96M
Earnings Per Share (EPS)	2.50

Full Income Statement

Balance Sheet

The company has 1.18 billion in cash and 556.93 million in debt, giving a net cash position of 620.23 million.

Cash & Cash Equivalents	1.18B
Total Debt	556.93M
Net Cash	620.23M
Net Cash Per Share	n/a
Equity (Book Value)	5.36B
Book Value Per Share	27.95
Working Capital	2.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 647.88 million and capital expenditures -70.40 million, giving a free cash flow of 577.49 million.

Operating Cash Flow	647.88M
Capital Expenditures	-70.40M
Free Cash Flow	577.49M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.01%, with operating and profit margins of 24.25% and 17.76%.

Gross Margin	81.01%
Operating Margin	24.25%
Pretax Margin	22.86%
Profit Margin	17.76%
EBITDA Margin	27.34%
EBIT Margin	24.25%
FCF Margin	21.16%

Dividends & Yields

BIT:1BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.65%
Shareholder Yield	-1.65%
Earnings Yield	4.76%
FCF Yield	5.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BMRN has an Altman Z-Score of 7.57.

Altman Z-Score	7.57
Piotroski F-Score	n/a